Humacyte (HUMA) Operating Leases (2020 - 2023)

Humacyte (HUMA) reported Operating Leases of $632000.0 for Q4 2023, down 9.71% year-over-year from $700000.0 in Q4 2022, and up 1.94% quarter-over-quarter from $620000.0 in Q1 2023.

Humacyte (HUMA) Operating Leases (2020 - 2023) Analysis & Trends

Humacyte (HUMA) has 4 years of Operating Leases data on file, last reported at $632000.0 in Q4 2023.

  • Operating Leases for Q4 2023 came in at $632000.0, down 9.71% year-over-year; the trailing twelve-month figure through Dec 2023 was $632000.0 (down 9.71% YoY), and the FY2023 annual result was $632000.0, down 9.71% from the prior year.
  • Operating Leases improved to $632000.0 in Q4 2023 per HUMA's latest filing, from $620000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $727000.0 in Q4 2020 and troughed at $620000.0 in Q1 2023.
  • A 4-year average of $671666.7 and a median of $670000.0 in 2022 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2022 and 2023: Operating Leases changed 0.0% in 2022, then decreased 9.71% in 2023.
  • A 4-year view of Operating Leases shows it stood at $727000.0 in 2020, then decreased by 3.71% to $700000.0 in 2021, then changed by 0.0% to $700000.0 in 2022, then decreased by 9.71% to $632000.0 in 2023.
  • Business Quant data shows HUMA's Operating Leases at $632000.0 in Q4 2023, $620000.0 in Q1 2023, and $700000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Humacyte 267.09 Mn 218.55 Mn -1.54 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 632,000.00
Mar 31, 2023 620,000.00
Dec 31, 2022 700,000.00
Sep 30, 2022 645,000.00
Jun 30, 2022 658,000.00
Mar 31, 2022 670,000.00
Dec 31, 2021 700,000.00
Sep 30, 2021 693,000.00
Dec 31, 2020 727,000.00